Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Feb;14(3-4):168-77.
doi: 10.1016/j.drudis.2008.10.005. Epub 2008 Dec 6.

Perispinal Etanercept for Neuroinflammatory Disorders

Affiliations
Review

Perispinal Etanercept for Neuroinflammatory Disorders

Edward Tobinick. Drug Discov Today. .

Abstract

Excess TNF is centrally involved in the pathogenesis of a variety of neuroinflammatory disorders, including Alzheimer's disease, other forms of dementia, intervertebral disc-related pain, and related disorders. TNF causes neuronal dysfunction, regulates synaptic mechanisms, and mediates amyloid-induced disruption of molecular mechanisms involved in memory. Perispinal administration of etanercept, a potent anti-TNF fusion protein, is a treatment modality whose rapid clinical effects may be related to modulation of these TNF-related mechanisms, particularly the role of TNF as a gliotransmitter capable of regulating synaptic transmission. This approach utilizes therapeutic delivery of etanercept across the dura via the cerebrospinal venous system, a confluence of the venous plexuses of the spine and the brain, in which flow is bi-directional owing to the absence of venous valves.

Similar articles

See all similar articles

Cited by 23 articles

See all "Cited by" articles

MeSH terms

Substances

LinkOut - more resources

Feedback